QNCX
Price
$0.16
Change
+$0.01 (+6.67%)
Updated
Feb 4 closing price
Capitalization
8.85M
26 days until earnings call
Intraday BUY SELL Signals
ZLAB
Price
$17.00
Change
+$0.57 (+3.47%)
Updated
Feb 4 closing price
Capitalization
1.86B
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

QNCX vs ZLAB

Header iconQNCX vs ZLAB Comparison
Open Charts QNCX vs ZLABBanner chart's image
Quince Therapeutics
Price$0.16
Change+$0.01 (+6.67%)
Volume$5.15M
Capitalization8.85M
Zai Lab
Price$17.00
Change+$0.57 (+3.47%)
Volume$1.61M
Capitalization1.86B
QNCX vs ZLAB Comparison Chart in %
QNCX
Daily Signal:
Gain/Loss:
ZLAB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
QNCX vs. ZLAB commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QNCX is a Hold and ZLAB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (QNCX: $0.16 vs. ZLAB: $17.00)
Brand notoriety: QNCX and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QNCX: 189% vs. ZLAB: 190%
Market capitalization -- QNCX: $8.85M vs. ZLAB: $1.86B
QNCX [@Biotechnology] is valued at $8.85M. ZLAB’s [@Biotechnology] market capitalization is $1.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QNCX’s FA Score shows that 0 FA rating(s) are green whileZLAB’s FA Score has 1 green FA rating(s).

  • QNCX’s FA Score: 0 green, 5 red.
  • ZLAB’s FA Score: 1 green, 4 red.
According to our system of comparison, both QNCX and ZLAB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QNCX’s TA Score shows that 4 TA indicator(s) are bullish while ZLAB’s TA Score has 5 bullish TA indicator(s).

  • QNCX’s TA Score: 4 bullish, 6 bearish.
  • ZLAB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ZLAB is a better buy in the short-term than QNCX.

Price Growth

QNCX (@Biotechnology) experienced а -95.00% price change this week, while ZLAB (@Biotechnology) price change was -1.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

QNCX is expected to report earnings on Mar 03, 2026.

ZLAB is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLAB($1.86B) has a higher market cap than QNCX($8.85M). ZLAB YTD gains are higher at: -3.628 vs. QNCX (-95.257). QNCX has higher annual earnings (EBITDA): -44.18M vs. ZLAB (-187.93M). ZLAB has more cash in the bank: 717M vs. QNCX (26.3M). QNCX has less debt than ZLAB: QNCX (18M) vs ZLAB (219M). ZLAB has higher revenues than QNCX: ZLAB (442M) vs QNCX (0).
QNCXZLABQNCX / ZLAB
Capitalization8.85M1.86B0%
EBITDA-44.18M-187.93M24%
Gain YTD-95.257-3.6282,626%
P/E RatioN/AN/A-
Revenue0442M-
Total Cash26.3M717M4%
Total Debt18M219M8%
FUNDAMENTALS RATINGS
QNCX vs ZLAB: Fundamental Ratings
QNCX
ZLAB
OUTLOOK RATING
1..100
677
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
9987
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZLAB's Valuation (25) in the Biotechnology industry is in the same range as QNCX (47). This means that ZLAB’s stock grew similarly to QNCX’s over the last 12 months.

ZLAB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that ZLAB’s stock grew similarly to QNCX’s over the last 12 months.

ZLAB's SMR Rating (96) in the Biotechnology industry is in the same range as QNCX (100). This means that ZLAB’s stock grew similarly to QNCX’s over the last 12 months.

ZLAB's Price Growth Rating (87) in the Biotechnology industry is in the same range as QNCX (99). This means that ZLAB’s stock grew similarly to QNCX’s over the last 12 months.

ZLAB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that ZLAB’s stock grew similarly to QNCX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QNCXZLAB
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 24 days ago
86%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
QNCX
Daily Signal:
Gain/Loss:
ZLAB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JRGRX32.250.50
+1.57%
JHancock Regional Bank R6
HSCVX13.660.21
+1.56%
Hunter Small Cap Value I
OSPPX7.170.06
+0.83%
Invesco SteelPath MLP Alpha Plus R6
RIVJX20.79-0.16
-0.76%
American Funds International Vntg R-5E
OTCJX26.26-0.40
-1.50%
MFS Mid Cap Growth R4

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been closely correlated with MREO. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if QNCX jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+9.28%
MREO - QNCX
86%
Closely correlated
-2.73%
CALC - QNCX
85%
Closely correlated
+8.37%
TPST - QNCX
84%
Closely correlated
-1.24%
RZLT - QNCX
83%
Closely correlated
-7.62%
GNTA - QNCX
83%
Closely correlated
-1.27%
More

ZLAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLAB has been closely correlated with LEGN. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ZLAB jumps, then LEGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLAB
1D Price
Change %
ZLAB100%
+3.47%
LEGN - ZLAB
72%
Closely correlated
-0.06%
MREO - ZLAB
72%
Closely correlated
-2.73%
QNCX - ZLAB
70%
Closely correlated
+9.28%
CALC - ZLAB
68%
Closely correlated
+8.37%
BDRX - ZLAB
64%
Loosely correlated
-11.04%
More